Live Updates: COVID-19 Cases
  • World 11,564,185
    World
    Confirmed: 11,564,185
    Active: 4,488,424
    Recovered: 6,538,868
    Death: 536,893
  • USA 2,982,928
    USA
    Confirmed: 2,982,928
    Active: 1,560,795
    Recovered: 1,289,564
    Death: 132,569
  • Brazil 1,604,585
    Brazil
    Confirmed: 1,604,585
    Active: 561,070
    Recovered: 978,615
    Death: 64,900
  • India 698,233
    India
    Confirmed: 698,233
    Active: 253,602
    Recovered: 424,928
    Death: 19,703
  • Russia 681,251
    Russia
    Confirmed: 681,251
    Active: 220,340
    Recovered: 450,750
    Death: 10,161
  • Peru 302,718
    Peru
    Confirmed: 302,718
    Active: 98,172
    Recovered: 193,957
    Death: 10,589
  • Spain 297,625
    Spain
    Confirmed: 297,625
    Active: 269,240
    Recovered: ?
    Death: 28,385
  • Chile 295,532
    Chile
    Confirmed: 295,532
    Active: 28,192
    Recovered: 261,032
    Death: 6,308
  • UK 285,416
    UK
    Confirmed: 285,416
    Active: 241,196
    Recovered: ?
    Death: 44,220
  • Mexico 256,848
    Mexico
    Confirmed: 256,848
    Active: 70,605
    Recovered: 155,604
    Death: 30,639
  • Italy 241,611
    Italy
    Confirmed: 241,611
    Active: 14,642
    Recovered: 192,108
    Death: 34,861
  • Iran 240,438
    Iran
    Confirmed: 240,438
    Active: 27,537
    Recovered: 201,330
    Death: 11,571
  • Pakistan 231,818
    Pakistan
    Confirmed: 231,818
    Active: 95,407
    Recovered: 131,649
    Death: 4,762
  • Saudi Arabia 209,509
    Saudi Arabia
    Confirmed: 209,509
    Active: 62,357
    Recovered: 145,236
    Death: 1,916
  • Turkey 205,758
    Turkey
    Confirmed: 205,758
    Active: 19,853
    Recovered: 180,680
    Death: 5,225
  • Germany 197,558
    Germany
    Confirmed: 197,558
    Active: 6,272
    Recovered: 182,200
    Death: 9,086
  • South Africa 196,750
    South Africa
    Confirmed: 196,750
    Active: 100,236
    Recovered: 93,315
    Death: 3,199
  • France 166,960
    France
    Confirmed: 166,960
    Active: 60,007
    Recovered: 77,060
    Death: 29,893
  • Bangladesh 162,417
    Bangladesh
    Confirmed: 162,417
    Active: 87,740
    Recovered: 72,625
    Death: 2,052
  • Canada 105,536
    Canada
    Confirmed: 105,536
    Active: 27,613
    Recovered: 69,239
    Death: 8,684
  • China 83,557
    China
    Confirmed: 83,557
    Active: 405
    Recovered: 78,518
    Death: 4,634
  • Netherlands 50,621
    Netherlands
    Confirmed: 50,621
    Active: 44,494
    Recovered: ?
    Death: 6,127
  • S. Korea 13,137
    S. Korea
    Confirmed: 13,137
    Active: 1,005
    Recovered: 11,848
    Death: 284
  • Australia 8,586
    Australia
    Confirmed: 8,586
    Active: 1,060
    Recovered: 7,420
    Death: 106
  • New Zealand 1,534
    New Zealand
    Confirmed: 1,534
    Active: 22
    Recovered: 1,490
    Death: 22

ICMR to conduct survey to estimate prevalence of COVID-19 infection among Indian population

Author at TechGenyz Health

The Indian Council of Medical Research in collaboration with other key stakeholders is conducting a population-based sero survey to estimate the prevalence of coronavirus infection among the Indian population.

According to an expert associated with the survey, the exercise can help to ascertain if there has been community transmission of the respiratory disease in these areas.

The survey would be conducted in 69 districts of 21 states and Union Territories, the apex health research body said in a statement on Tuesday.

Maharashtra, Rajasthan, Uttar Pradesh, Gujarat, Madhya Pradesh, Chhattisgarh, West Bengal, Assam and Bihar are some of the states where the survey would be conducted.

The household-level cross-sectional survey will cover 24,000 adults distributed equally across four strata of districts categorized on the basis of COVID-19 cases, the ICMR said in a statement.

The move was announced as the death toll due to COVID-19 rose to 2,293 and the total number of cases climbed to 70,756 in the country on Tuesday, according to the Union health ministry data.

As part of the study, people from Red, Orange and Green zones in a district will be tested for COVID-19 at random to check if they have developed antibodies against the infection even though they are asymptomatic or show mild symptoms, the expert said.

"The ICMR, New Delhi, in collaboration with the Department of Health and Family Welfare, Government of India and National Centre for Disease Control with support from state health departments and key stakeholders, including WHO, India is conducting a community-based serosurvey to estimate the prevalence of SARS-CoV-2 infection in the Indian population," the statement said.

The survey is coordinated by ICMR's National Institute of Epidemiology (NIE) and National Institute of Research in Tuberculosis (NIRT), Chennai.

The survey will involve collection of venous blood samples from 400 randomly selected individuals (one per household) from 10 clusters in each district.

"Sera from these individuals will be tested for the presence of IgG antibodies using ELISA test developed by ICMR-National Institute of Virology (NIV), Pune. The results of the survey will provide information about the spread of SARS-CoV-2 infection (COVID-19) in different parts of the country," the ICMR said.

The officials said the study would have started earlier as it was planned to be conducted with the rapid antibody test kits brought from China. But after these test kits showed inaccurate results in some places, the study had to be postponed.

The health ministry said the survey would be conducted in six districts of Maharashtra, including Beed, Jalgaon, Ahmednagar, Sangli; three districts of Rajasthan like Dausa, Jalore; nine districts of Uttar Pradesh like Bareilly, Unnao, Saharanpur, Mau; three districts of Gujarat like Mahisagar, Narmada; three districts of Madhya Pradesh like Ujjain, Gwalior.

Besides the health ministry is also initiating hospital-based surveillance to monitor the trend of infection in all districts.

The survey will be conducted at 10 health facilities (six public and four private) and would test outpatient attendees and pregnant women among the low-risk group, and health care workers among the high-risk population.

At least 100 samples of healthcare workers from selected districts per week and 400 per month would be tested.

Besides, 50 samples each of the outpatient attendees and pregnant women per week and 200 samples per month would be collected, the document stated.

Throat and nasal swabs will be collected for RT-PCR tests and samples should be tested in a one-time pool of 25, it said.

We Are Hiring

Subscribe